Feasibility and efficacy of salvage allogeneic stem cell transplantation in AML patients relapsing after autologous stem cell transplantation
Evgenii Shumilov(University Hospital Münster), Thomas Pabst(University Hospital of Bern), Marie-Noëlle Kronig(University Hospital of Bern), Michael Medinger(University Hospital of Basel), Yishai Ofran(Shaare Zedek Medical Center), Susanne Buerki(University Hospital of Bern), Myriam Legros(University of Bern), Inna Shakhanova(University Hospital of Bern), Ulrike Bacher(Hattiesburg Clinic), Jörg Halter(University Hospital of Basel), Nicole Schmidt(Universitätsmedizin Göttingen), Sabine Gerull(University Hospital of Basel), Behrouz Mansouri Taleghani(University of Bern), Johanna Flach(University of California, San Francisco), Jakob Passweg(University Hospital of Basel)
Cited by 7
Related Papers
Solid Cancers after Bone Marrow Transplantation
|New England Journal of Medicine|1997|968
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells
|Nature|2014|630
One million haemopoietic stem-cell transplants: a retrospective observational study
|The Lancet Haematology|2015|434
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission
|New England Journal of Medicine|2020|432